K Crosson1, E Eisner, C Brown, J Ter Maat. 1. Office of Education and Special Initiatives, National Cancer Institute, Bethesda, Maryland 20892, USA.
Abstract
BACKGROUND: Participation of patients in cancer clinical trials is disappointingly low and several physician-based factors are thought to be responsible. METHODS: In 1998-1999, the National Cancer Institute (NCI) conducted a probability survey of three primary care physician groups to gain a better understanding of the barriers to clinical-trial patient accrual from their perspective. RESULTS: Findings from this survey of 706 primary care physicians indicate that the vast majority (98%) refer their patients with cancer to a specialist for cancer treatment and rarely bring up the topic of cancer clinical trials. Frequently cited reasons for not mentioning clinical trials are preferring to leave that discussion to the oncologist (41%) and being unaware of any clinical trials that may be available for the patient (37%). CONCLUSION: Primary care physicians may represent an important untapped resource for introducing the concept of clinical trials as an option to newly diagnosed cancer patients.
BACKGROUND: Participation of patients in cancer clinical trials is disappointingly low and several physician-based factors are thought to be responsible. METHODS: In 1998-1999, the National Cancer Institute (NCI) conducted a probability survey of three primary care physician groups to gain a better understanding of the barriers to clinical-trial patient accrual from their perspective. RESULTS: Findings from this survey of 706 primary care physicians indicate that the vast majority (98%) refer their patients with cancer to a specialist for cancer treatment and rarely bring up the topic of cancer clinical trials. Frequently cited reasons for not mentioning clinical trials are preferring to leave that discussion to the oncologist (41%) and being unaware of any clinical trials that may be available for the patient (37%). CONCLUSION: Primary care physicians may represent an important untapped resource for introducing the concept of clinical trials as an option to newly diagnosed cancerpatients.
Authors: Margo Michaels; Elisa S Weiss; John A Guidry; Natasha Blakeney; Liz Swords; Brian Gibbs; Samantha Yeun; Bruce Rytkonen; Robert Goodman; S Lisbeth Jarama; Amanda L Greene; Shilpa Patel Journal: J Cancer Educ Date: 2012-03 Impact factor: 2.037
Authors: Malaika N Woods; Kari Jo Harris; Matthew S Mayo; Delwyn Catley; Monica Scheibmeir; Jasjit S Ahluwalia Journal: J Natl Med Assoc Date: 2002-07 Impact factor: 1.798
Authors: Douglas J Weckstein; Christian A Thomas; Ivette F Emery; Barbara F Shea; Alison Fleury; Margaret E White; Elizabeth Chase; Cindy Robinson; Stacey Frazier; Christine Pilar Journal: J Oncol Pract Date: 2011-09 Impact factor: 3.840
Authors: Carma L Bylund; Elisa S Weiss; Margo Michaels; Shilpa Patel; Thomas A D'Agostino; Emily B Peterson; Maria Christina Binz-Scharf; Natasha Blakeney; M Diane McKee Journal: Clin Trials Date: 2017-07-11 Impact factor: 2.486
Authors: Margo Michaels; Thomas A D'Agostino; Natasha Blakeney; Elisa S Weiss; Maria C Binz-Scharf; Mitch Golant; Carma L Bylund Journal: J Cancer Educ Date: 2015-03 Impact factor: 2.037
Authors: S Manne; D Kashy; T Albrecht; Y-N Wong; A Lederman Flamm; A B Benson; S M Miller; Linda Fleisher; J Buzaglo; N Roach; M Katz; E Ross; M Collins; D Poole; S Raivitch; D M Miller; T G Kinzy; T Liu; N J Meropol Journal: Eur J Cancer Care (Engl) Date: 2014-01-28 Impact factor: 2.520